“We are pleased to be expanding access into Northern Ohio. MedMark offers unrivaled care for those struggling with opioid addiction, and will continue that practice as we welcome patients in our newest facility." - Frank Baumann, Chief Operating Officer.
KENT, Ohio (PRWEB) April 23, 2020
BayMark Health Services has announced the opening of MedMark Treatment Centers Kent, expanding access to opioid addiction treatment services into northern Ohio. Conveniently located at 2500 State Route 59, 30 minutes outside of Akron, MedMark Kent is accepting new patients and has safety precautions in place to do so with our patient’s health top of mind as we address both the coronavirus pandemic and the opioid epidemic.
MedMark Kent will provide medically-supervised, medication-assisted treatment (MAT), administering methadone or buprenorphine, counseling and support services for those seeking treatment for opioid use disorder. As essential medical facilities, MedMark Treatment Centers are accepting new patients and following all CDC guidelines for social distancing and sanitizing throughout the facility.
“Ohio is currently experiencing the impact of two significant public health emergencies,” commented David K. White, Ph.D., CEO of BayMark Health Services. “The opioid epidemic has hit Ohio incredibly hard, and a significant amount of loss has been experienced throughout the state over many years. Now the coronavirus pandemic is impacting all citizens and intensifying that loss. We proceeded with the opening of our new location in Kent to ensure that as many people as possible have access to opioid treatment, both during this stressful and uncertain time, as well as once the coronavirus has passed.”
MedMark Treatment Centers are known across the country as providers of comprehensive, individualized treatment for opioid use disorder. Through medication management and counseling, MAT reduces the symptoms of withdrawal and cravings, paving the way for patients to focus on addressing the causes and consequences of their addiction and supporting them to regain stability in their lives. Additionally, MedMark Kent will provide addiction education, relapse prevention, lab testing, coordinated care for pregnant women and linkages to community resources to assist patients on their path to recovery.
Chief Operating Officer Frank Baumann added, “We are pleased to be expanding access into Northern Ohio. MedMark offers unrivaled care for those struggling with opioid addiction, and will continue that practice as we welcome patients in our newest facility. No matter what circumstances we face, our staff puts our patient’s safety, well-being and recovery first. ”
For more information on MedMark and our services visit: http://www.MedMark.com.
To inquire about admission or make a referral, contact Kathleen Mahoney, Treatment Center Director, at 330.552.4000.
About BayMark Health Services:
BayMark Health Services provides medication-assisted treatment to 53,000+ patients in recovery from substance use disorder across the United States and Canada. Our outpatient programs deliver medically-supervised treatment, in a variety of modalities and settings, to meet the diverse needs of our patients who struggle with the use of opioids, alcohol and other prescription and illicit substances.
The BayMark continuum of patient-focused services includes: highly structured opioid treatment programs utilizing methadone or buprenorphine and outpatient buprenorphine treatment programs, both of which incorporate counseling as part of an individualized treatment plan for opioid use disorder. Additionally, ambulatory withdrawal management services with naltrexone therapy, and inpatient detoxification services are offered for a variety of substance use disorders.